XXXX in @entity6 .

@entity1 @entity239 @entity6 @entity164 @entity158 @entity2412 @entity413 @entity10 @entity25
OBJECTIVE: The aim of this study was to evaluate the prevalence of @entity239 ( @entity239 ) in @entity1 with @entity6 ( @entity6 ). SUBJECTS: The study included 100 consecutive unselected @entity1 with @entity6 attending our @entity6 clinic. @entity1 were divided into two groups: 45 @entity1 with @entity164 1 @entity6 and 55 @entity1 with @entity164 2 @entity6 . A group of 50 healthy hospital staff members served as controls. The @entity239 was diagnosed according to the 1990 American College of Rheumatology criteria. Counts of 18 tender points were performed by thumb palpation and assessed by dolorimeter. Routine biochemical tests and levels of HbA(1c) were recorded in each @entity1 . RESULTS: The main outcome measure was the association of @entity239 with @entity6 . @entity239 was diagnosed in 17 @entity1 (17%) with @entity6 and in only one (2%) healthy control ( P=0.008). No differences in @entity1 were noted in the prevalence of @entity239 between @entity164 1 and @entity164 2 @entity6 (18.5% vs 15.5%, respectively). @entity1 with both @entity239 and @entity6 had significantly higher levels of HbA(1c) than @entity6 @entity1 without @entity239 (9.2+/-1.1% vs 6.4+/-1.5%) ( P<0.05). Similarly, the numbers of tender points, @entity158 scores, and the prevalence of @entity25 , fatigue, and @entity10 were higher in this group of @entity1 . A significant correlation was observed between the numbers of tender points and HbA(1c) levels in the @entity6 @entity1 with @entity239 ( r=0.72, P=0.027). CONCLUSION: @entity239 is a common finding in @entity1 with types 1 and 2 @entity6 , and its prevalence could be related to control of the disease. As with other @entity2412 , @entity239 might be prevented by improved control of blood @entity413 levels.
